#United States #AI Imaging #Los Gatos #GE HealthCare #Laza Medical

Laza Medical's Major Series B Financing

Laza Medical, a pioneering company in the field of AI-powered robotic imaging solutions for cardiac interventions, has successfully raised up to $160 million in Series B financing. This funding round was notably led by GE HealthCare, a major player in medical imaging technology, with participation from existing investors such as Unorthodox Ventures, PA MedTech, and AMED.

Transforming Cardiac Care

The primary aim of this substantial investment is to revolutionize the cardiac catheterization laboratory (cath lab) through the integration of advanced intelligent imaging technology. This innovative system is designed to simplify intricate procedures, increase autonomy among medical teams, and reduce the burden of resource constraints faced in modern healthcare settings.

Jyoti Gera, CEO of Cardiovascular and Interventional Solutions at GE HealthCare, expressed excitement about the collaboration, stating, "The future of cardiac intervention must be one where access, consistency, and quality of care are no longer barriers to better outcomes." He emphasized the importance of integrating various imaging modalities to facilitate efficient workflows, which will not only enhance current operations but also set the stage for future robotic-assisted interventions.

Meeting Complexities in Cardiac Procedures

As cardiovascular procedures grow increasingly complex, medical professionals require more intuitive and reliable imaging guidance. The combination of AI and robotics from Laza Medical aims to meet these demands, offering a simplified approach to procedural imaging that expands the reach of specialized imaging expertise. This will empower care teams, enabling them to navigate and guide intricate cardiac interventions with improved confidence.

Dr. Firas Zahr, an expert in Interventional Cardiology from Oregon Health Sciences University Hospital, highlighted the pivotal role high-quality imaging plays in successful medical cases. He noted, "Consistent anatomic and spatial context simplifies procedures and helps clinicians navigate the anatomy with confidence and precision."

A New Era in Cath Labs

Amr Salahieh, founder and Board Chairman at Laza Medical, believes this funding marks a significant shift for cath labs. He stated, "The cath lab is poised for a fundamental evolution, and intelligent imaging powered by AI will play a defining role in what comes next." The support from investors validates Laza's approach and underscores the potential impact of their solution in streamlining processes, reducing variability, and enhancing the quality of cardiac procedures overall.

The current version of the Laza Medical System is still under development and is not yet approved for commercial use in any region. However, the company's strong focus on using AI to innovate cardiac imaging signifies their commitment to delivering top-tier medical solutions that improve patient outcomes.

About Laza Medical

Laza Medical operates as a privately held company under the Shifamed umbrella, concentrating on creating high-quality AI-driven robotic imaging solutions tailored for cardiovascular interventions. Their mission aligns with the broader vision of making healthcare more efficient and accessible, ensuring that patients receive the best possible care.

For further details about Laza Medical and its innovative technologies, one can visit their official website at www.lazamedical.com.

About Shifamed

Founded by serial entrepreneur Amr Salahieh, Shifamed is an innovation hub that specializes in medical advancements. The company is committed to developing market-ready solutions that minimize risks and maximize patient impact, ultimately helping individuals lead healthier lives. With a strong focus on next-generation cardiac cath lab innovations, Shifamed aims to integrate breakthroughs in advanced imaging, AI, and robotics seamlessly into patient care.